Prostatic multi-parametric magnetic resonance imaging (MP-MRI) has recently had a wide development becoming a key tool in the diagnostic and therapeutic decisions in prostate cancer (Pca). The fast development both in technology and in reading (PIRADS V2) requires a continuous updating of knowledge within this area. The aim of this article is to present an updated revision of technical aspects, reading patterns and prostatic MP-MRI in Pca, with a multidisciplinary approach. Currently guidelines establish the use of the MP-MRI when there is a high PSA and a negative prostatic biopsy; tumor staging; evaluation in candidates to active surveillance; focal treatments plans and tumoral recurrence evaluation. Although it is used in other indications in some centers, like its use in patients suspicious of Pca but with no previous biopsy, there is still the need of a cost/benefit assessment for its use to be wider.
Radiologia. 2017 Feb 21 [Epub ahead of print]
V Catalá, J C Vilanova, J M Gaya, F Algaba, T Martí
Servicio de Radiología, Fundació Puigvert, Barcelona, España. Electronic address: ., Departamento de Radiología, Clínica Girona, Institut Català de la Salut, IDI; Departamento de Ciencias Médicas, Facultad de Medicina, Universitat de Girona, Girona, España., Servicio de Urología, Fundació Puigvert, Universidad Autónoma de Barcelona, Barcelona, España., Servicio de Laboratorio, Fundació Puigvert, Barcelona, España., Servicio de Radiología, Fundació Puigvert, Barcelona, España.